| name | icsm-avoid-tt-for-diabetes-prevention |
| description | The guideline recommends against using testosterone therapy alone to prevent or treat diabetes in men with hypogonadism. Clinicians should consider this recommendation when contemplating testosterone to improve HbA1c or insulin resistance and questioning whether testosterone can replace glucose-lowering therapy or be used for diabetes management. |
Avoid testosterone therapy alone to prevent or treat diabetes in hypogonadism
STEP 1 — Gather Information
Confirm hypogonadism: presence of symptoms (e.g., low libido, ED, fatigue) and total testosterone <12 nmol/L on two morning fasting samples; assess diabetes status: HbA1c, fasting plasma glucose, oral glucose tolerance test if indicated; review current glucose‑lowering medications and lifestyle interventions.
STEP 2 — Rule In / Rule Out
Is the patient hypogonademic and being considered for testosterone therapy to prevent or treat diabetes? If yes, proceed to Step 3; if no, do not initiate testosterone for diabetes purposes.
STEP 3 — Classify or Stratify
Stratify glycemic status: normal glucose tolerance, prediabetes (HbA1c 5.7‑6.4%), or type 2 diabetes (HbA1c ≥6.5%); note any existing glucose‑lowering therapy.
STEP 4 — Decide
Do not use testosterone monotherapy for diabetes prevention or glycemic control; manage diabetes per standard guidelines (lifestyle, metformin, etc.) and consider testosterone only for hypogonadism symptoms per other ICSM recommendations.
Clinical Guardrails / Mimics / Pitfalls
Do not rely on testosterone to replace glucose‑lowering agents; testosterone may modestly improve insulin resistance but is insufficient as sole therapy; monitor hematocrit, PSA, and symptoms; avoid in men seeking fertility; be aware that weight loss and exercise raise endogenous testosterone more effectively.
Concrete Clinical Example
A 58‑year‑old man with hypogonadism (total testosterone 9 nmol/L) and prediabetes (HbA1c 6.0%) asks whether a testosterone gel can prevent diabetes. The clinician advises lifestyle modification and metformin per ADA guidelines, not testosterone alone.
Source: Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 20 on Sexual Medicine (ICSM 2024), International Society for Sexual Medicine, 2025, DOI: 10.1093/sxmrev/qeaf036
